Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 14/20 | 0.67 |
| ▸ | CNR2 | P34972 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL708712 | 0.91 | CNR1 (0.70) | CNR1CNR2 | |
| SCHEMBL6123512 | 0.90 | CNR1 (0.69) | CNR1CNR2 | |
| SCHEMBL10087194 | 0.87 | CNR1 (0.68) | CNR1CNR2 | |
| SCHEMBL10087243 | 0.87 | CNR1 (0.67) | CNR1CNR2 | |
| SCHEMBL10087193 | 0.85 | CNR1 (0.82) | CNR1CNR2 | |
| SCHEMBL706792 | 0.83 | CNR1 (0.68) | CNR1CNR2 | |
| SCHEMBL10087161 | 0.83 | CNR1 (0.69) | CNR1CNR2 | |
| SCHEMBL702992 | 0.82 | CNR1 (0.73) | CNR1CNR2 | |
| SCHEMBL6123693 | 0.82 | CNR1 (0.73) | CNR1CNR2 | |
| SCHEMBL6123663 | 0.82 | CNR1 (0.72) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2121617-B1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA AS (DK) | 2014-01-22 | — | — | EP | disclosed |
| US-8124634-B2 | CB1 receptor modulators | 7TM PHARMA A/S (DK) | 2012-02-28 | — | — | US | disclosed |
| US-20100010061-A1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA A/S (DK) | 2010-01-14 | — | — | US | disclosed |
| EP-2121617-A1 | CB1 RECEPTOR MODULATORS | 7TM Pharma A/S (DK) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008075012-A1 | CB1 RECEPTOR MODULATORS | 7TM PHARMA A/S (DK) | 2008-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100010061-A1 | CB1 RECEPTOR MODULATORS | CNR1, CNR2, GPR6 | CNR1 1/4885CNR2 2/4885MAPT 4450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.